Is Paxlovid Still Worth It?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is Paxlovid Still Worth It?

Published:2024-02-27 Issue:1 Volume:79 Page:111-114
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Faust Jeremy Samuel¹^ORCID,Meyerowitz-Katz Gideon²

Affiliation:

1. Brigham and Women's Hospital Department of Emergency Medicine, Mass General Brigham Division of Health Services Research, Harvard Medical School , Boston, Massachusetts, USA

2. School of Health and Society, University of Wollongong , New South Wales , Australia

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciae106/57400617/ciae106.pdf

Reference8 articles.

1. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19;Hammond;N Engl J Med,2022

2. Nirmatrelvir use and severe Covid-19 outcomes during the Omicron surge;Arbel;N Engl J Med,2022

3. Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of Omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study;Aggarwal;Lancet Infect Dis,2023

4. Patient characteristics and costs associated with COVID-19–related medical care among Medicare fee-for-service beneficiaries;Tsai;Ann Intern Med,2021

5. Inpatient costs of treating patients with COVID-19;Kapinos;JAMA Netw Open,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP